Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19
Antoine Rauch(Inserm), Boualem Sendid(Lille Inflammation Research International Center), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille), Julien Goutay(Centre Hospitalier Universitaire de Lille), Julien Labreuche(ASTER), David Launay(Inserm), Julien Poissy(Centre National de la Recherche Scientifique), Delphine Garrigue(Society of Critical Care Medicine), Delphine Corseaux(Inserm), Marie‐Charlotte Chopin, Senna Staessens(Inserm), Fanny Lassalle(Inserm), Guillaume Lefèvre(Université de Lille), Éric Kipnis(Centre National de la Recherche Scientifique), Myriam Labalette(Université d'Angers), Éric Van Belle, Emmanuelle Jeanpierre(Inserm), Peter J. Lenting(Inserm), Enagnon Kazali Alidjinou(Université de Lille), Anne Goffard(Centre National de la Recherche Scientifique), Simon F. De Meyer(Research Institute for Chromatography), Morgan Caplan(Centre Hospitalier Universitaire de Lille), Mouhamed Djahoum Moussa(Inserm), Ilka Engelmann(Centre Hospitalier Universitaire de Lille), Sophie Susen(Inserm), Flavien Vincent(Valve (United States)), Dominique Deplanque(Inserm), Régis Bordet(Université de Lille), Daniel Mathieu(Centre Hospitalier Universitaire de Lille), Annabelle Dupont(Inserm), Karine Faure(Inserm), Bart Staels(Inserm), M. Lambert(Hôpital Claude Huriez), Alain Duhamel(Université de Lille)
Cited by 84
Related Papers
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901